Premium functions are now FREE OF CHARGE due to the modification of the investment data Data developments may cause some parts work incorrectly Incorrect sections - Financial statements, Earnings upcoming dates and calendars Please take our apologise. It will be fixed soon

BIOR - Biora Therapeutics Inc

Close
0.7474
0.027   3.653%

Share volume: 150,843
Last Updated: Fri 14 Jun 2024 10:00:01 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 12.15%

PREVIOUS CLOSE
CHG
CHG%
$0.72
0.03
3.79%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
4.97%
1 Month
4.53%
3 Months
-33.27%
6 Months
-45.04%
1 Year
-82.54%
2 Year
16.78%
Key data
Stock price
$0.75
P/E Ratio 
-0.24
DAY RANGE
$0.70 - $0.75
EPS 
-$5.45
52 WEEK RANGE
$0.48 - $4.35
52 WEEK CHANGE
-$0.83
MARKET CAP 
26.820 M
YIELD 
N/A
SHARES OUTSTANDING 
35.884 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08/12/2024
BETA 
0.37
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$168,573
AVERAGE 30 VOLUME 
$329,842
Company detail
CEO: Harry Stylli
Region: US
Website: https://www.progenity.com/
Employees: 157
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

progenity helps patients and their families prepare for life, with medically relevant health information starting before conception, through pregnancy, childhood, and adulthood. using our highly-complex molecular diagnostic testing, healthcare providers can access the most advanced genomic technology to guide patient care at critical life stages.

Recent news